🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Geng Li

Beijing University of Chinese Medicine

ORCID: 0000-0002-2441-2427

Also affiliated with Peking University, Northwest A&F University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands”.

Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands

Medical Oncology(2023)10.1007/s12032-023-01975-1

N/A

0DataRank · unranked

7 citations

Shahryar Khoshtinat Nikkhoi, Arash Hatefi, Geng Li

A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide

Antibodies(2024)10.3390/antib13030075

N/A

0DataRank · unranked

2 citations

Shahryar Khoshtinat Nikkhoi, Hajar Owji, Geng Li, Mohammad Massumi, Jessica A. Cervelli +3 more

Engineered tumor-tropic mesenchymal stem cells as targeted therapeutic delivery systems for refractory Ovarian cancer

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114584

N/A

0DataRank · unranked

2 citations

Mohammad Massumi, Hajar Owji, Ge Yang, Eugenia Girda, Arash Hatefi +1 more